Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03999151 · ClinicalTrials.gov registry record · NA
Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)
A NA study of Prostate Cancer, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 1
- Study location
NCT03999151: Active NA study of Prostate Cancer, sponsored by University of California, San Francisco.
NCT03999151 is a NA study of Prostate Cancer that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 204 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03999151, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 1
- Study location
Study Summary
The Prostate 8-II study is a randomized controlled trial of testing different combinations of educational and supportive tools related to diet and exercise to evaluate biological, clinical, and quality of life outcomes in men choosing radical prostatectomy as treatment for prostate cancer.
Primary Outcome
The median time in months to PSA recurrence after surgery will be evaluated using prespecified biochemical recurrence (2x PSA ≥ 0.2) and detectable (2x PSA ≥ 0.03) PSA thresholds, at the time of analysis. A log-rank test to evaluate the time to recurrence among groups and multivariate Cox proportional hazards regression will be used to obtain a hazard ratio for the time to recurrence.
Conditions Studied
Interventions
- BEHAVIORAL Exercise and Diet
Study Locations (1)
California
- University of California, San Francisco (UCSF) - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2018-05-11 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What the registry record for NCT03999151 still lists
NCT03999151 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise and Diet is the first listed.
NCT03999151 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03999151 about?
NCT03999151 is a clinical study titled "Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)". The Prostate 8-II study is a randomized controlled trial of testing different combinations of educational and supportive tools related to diet and exercise to evaluate biological, clinical, and quality of life outcomes in men choosing radical prostatectomy as treatment for prostate cancer.
What is the current status of trial NCT03999151?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2018-05-11. Estimated completion is 2028-08-31.
What conditions does trial NCT03999151 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT03999151?
The interventions under investigation include: Exercise and Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03999151?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03999151 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03999151's enrollment target sits among peer trials
204 219th of 735 higher than 517 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI